BioCentury
ARTICLE | Company News

Serenex, J&J deal

November 4, 2002 8:00 AM UTC

JNJ’s Johnson & Johnson Pharmaceutical R&D unit will use Serenex’s Proteome Mining technology to screen compounds and identify drug targets. ...